Showing results (251-260 of 344) with videos related to

Sort By:
Pageof 35
British Journal of Cancer|January 31, 2018
Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)Jong-Mu Sun, Ki Hyeong Lee, Bong-Seog Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2019
The First-week Proliferative Response of Peripheral Blood PD-1+CD8+ T Cells Predicts the Response to Anti-PD-1 Therapy in Solid TumorsKyung Hwan Kim, Jinhyun Cho, Bo Mi Ku, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint InhibitorYoujin Kim, Chu Hyun Kim, Ho Yun Lee, et al.
Molecular Cancer Research : MCR|June 17, 2010
Matrix metalloproteinase-1 expression can be upregulated through mitogen-activated protein kinase pathway under the influence of human epidermal growth factor receptor 2 synergized with estrogen receptorHae Hyun Jung, Yeon Hee Park, Hyun Jung Jun, et al.
Future Oncology (London, England)|February 9, 2019
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancerKen Kato, Manish A Shah, Peter Enzinger, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2014
Is there any predictor for clinical outcome in EGFR mutant NSCLC patients treated with EGFR TKIs?Ji Yun Lee, Sung Hee Lim, Moonjin Kim, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2019
Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgeryWon Kyung Cho, Dongryul Oh, Hong Kwan Kim, et al.
Cancers|April 16, 2020
Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal CancerHan Gyul Yoon, Dongryul Oh, Yong Chan Ahn, et al.
Annals of Surgical Oncology|February 14, 2014
Pretreatment clinical mediastinal nodal bulk and extent do not influence survival in N2-positive stage IIIA non-small cell lung cancer patients treated with trimodality therapyHyebin Lee, Yong Chan Ahn, Hongryull Pyo, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|June 24, 2024
Practice pattern and risk of not receiving planned surgery after neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinomaTae Hee Hong, Tae Ho Kim, Genehee Lee, et al.
Pageof 35